title: Optic glioma in children: surveillance, resection, or irradiation?
abstract: Eighty-seven consecutive children with newly diagnosed optic glioma were managed at University of Toronto hospitals 1958-1990. Overall the 10-year survival, relapse-free survival and freedom from second relapse rates were 84%, 68% and 85%. Twenty-seven patients relapsed or progressed, of whom 40% were free of a second relapse 10 years after the first relapse. Fourteen patients had a second relapse. Thirteen are dead. None survived 5 years after second relapse. Patients with anteriorly located tumors (N = 35), which involved the optic nerve, or chiasm and optic nerves, fared better than those with posteriorly located tumors (N = 52) with spread beyond the chiasm, 10-year survival 95% versus 76%, (p = .02), 10-year relapse-free survival 80% versus 59% (p = .02), respectively. For posterior tumors primary irradiation was more effective than primary subtotal resection for prevention of subsequent relapse, 10-year relapse-free survival 75% versus 41% (p = .02), but salvage therapy was, in part, successful and multivariate analysis of prognostic factors influencing survival for posterior tumors indicated that neither primary resection nor primary irradiation were significant factors. For first relapse, primary irradiation and the presence of neurofibromatosis were the significant favorable factors. Since 1977 and for posterior optic glioma subtotal resection or surveillance were used in 21/29 (72%) patients compared with 4/23 (17%) previously. Ten-year survival rates before and after 1977 were 78% and 67% and 10-year relapse-free survival 64% and 56%, respectively.
authors.affiliation: Department of Hematology/Oncology, Hospital for Sick Children, Toronto, Ontario, Canada.
authors.forename: D
authors.initials: D
authors.lastname: Jenkin
authors.forename: S
authors.initials: S
authors.lastname: Angyalfi
authors.forename: L
authors.initials: L
authors.lastname: Becker
authors.forename: M
authors.initials: M
authors.lastname: Berry
authors.forename: R
authors.initials: R
authors.lastname: Buncic
authors.forename: H
authors.initials: H
authors.lastname: Chan
authors.forename: M
authors.initials: M
authors.lastname: Doherty
authors.forename: J
authors.initials: J
authors.lastname: Drake
authors.forename: M
authors.initials: M
authors.lastname: Greenberg
authors.forename: B
authors.initials: B
authors.lastname: Hendrick
mesh_terms: D000293:Adolescent; D001254:Astrocytoma / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D002648:Child; D002675:Child, Preschool; D003390:Cranial Nerve Neoplasms / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D016609:Neoplasms, Second Primary / Q000453:epidemiology; D009864:Ontario / Q000453:epidemiology; D009897:Optic Chiasm; D009901:Optic Nerve Diseases / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D011379:Prognosis; D012189:Retrospective Studies; D016879:Salvage Therapy; D015996:Survival Rate